SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-295954
Filing Date
2014-08-05
Accepted
2014-08-05 17:00:59
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d756248d10q.htm 10-Q 471143
2 EX-3.3 d756248dex33.htm EX-3.3 8584
3 EX-31.1 d756248dex311.htm EX-31.1 8257
4 EX-31.2 d756248dex312.htm EX-31.2 8427
5 EX-32.1 d756248dex321.htm EX-32.1 5179
  Complete submission text file 0001193125-14-295954.txt   4577916

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgnt-20140630.xml EX-101.INS 615500
7 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20140630.xsd EX-101.SCH 44281
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20140630_cal.xml EX-101.CAL 75342
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20140630_def.xml EX-101.DEF 284928
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20140630_lab.xml EX-101.LAB 346881
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20140630_pre.xml EX-101.PRE 339723
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 141016886
SIC: 2834 Pharmaceutical Preparations